
A literature review indicates that intravitreal administration of anti-VEGF drugs are effective for treating DME, but close attention should be paid to the potential for elevated IOP, cataract progression.


A literature review indicates that intravitreal administration of anti-VEGF drugs are effective for treating DME, but close attention should be paid to the potential for elevated IOP, cataract progression.

Study: Older age and eyes with severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy had a higher risk of a vision loss event.

Option has a broader biologic effect for patients.